LEONID PORETSKY, MD
Osteopathic Medicine in New York, NY
License number
New York 155121
Category
Osteopathic Medicine
Type
Internal Medicine
License number
New York 155121
Category
Osteopathic Medicine
Type
Endocrinology, Diabetes & Metabolism
Address
Address
2
317 St Fierman Hall FL 7TH, New York, NY 10003
PO Box 95000, Philadelphia, PA 19195
PO Box 95000, Philadelphia, PA 19195
Phone
(212) 420-2226
Personal information
See more information about LEONID PORETSKY at radaris.comName
Address
Phone
1025 5Th Ave #8ES, New York, NY 10028
1025 5Th Ave, New York, NY 10028
101 12Th St, New York, NY 10011
1025 5Th Ave, New York, NY 10028
1025 5Th St, New York, NY 10028
Organization information
See more information about LEONID PORETSKY at bizstanding.comLeonid Poretsky MD
520 E 70 St, New York, NY 10021
Categories:
Clinics & Medical Centers, Endocrinology & Metabolism Physicians & Surgeons
Site:
Phone:
(212) 746-6290 (Phone)
Leonid Poretsky MD
317 E 17 St, New York, NY 10003
Industry:
Internist
Phone:
(212) 420-2226 (Phone)
Leonid Poretsky
Beth Israel Medical Center Department - Leonid Poretsky MD
317 E 17 St #7, New York, NY 10003
Categories:
Endocrinology & Metabolism Physicians & Surgeons
Phone:
(212) 420-2226 (Phone)
Professional information
See more information about LEONID PORETSKY at trustoria.com
Leonid Poretsky, New York NY
Leonid Poretsky, New York NY
Specialties:
Endocrinologist
Address:
317 E 17Th St, New York, NY 10003
Education:
Saint Petersburg Pavlov State Medical University - Doctor of Medicine
Beth Israel Deaconess Medical Center - Fellowship - Endocrinology
Coney Island Hospital - Residency - Family Medicine
Beth Israel Deaconess Medical Center - Fellowship - Endocrinology
Coney Island Hospital - Residency - Family Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Endocrinology and Metabolism (Internal Medicine)
Dr. Leonid Poretsky, New York NY - MD (Doctor of Medicine)
Dr. Leonid Poretsky, New York NY - MD (Doctor of Medicine)
Specialties:
Endocrinology, Diabetes & Metabolism, Endocrinology & Metabolism
Address:
Beth Israel Medical Center Endo
317 E 17Th St SUITE 7, New York 10003
(212) 420-2226 (Phone)
317 E 17Th St SUITE 7, New York 10003
(212) 420-2226 (Phone)
Certifications:
Diabetes, Metabolism & Endocrinology, 1985, Internal Medicine, 1983
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Beth Israel Medical Center Endo
317 E 17Th St SUITE 7, New York 10003
Beth Israel Medical Center - Kings Highway Division
3201 Kings Hwy, Brooklyn 11234
317 E 17Th St SUITE 7, New York 10003
Beth Israel Medical Center - Kings Highway Division
3201 Kings Hwy, Brooklyn 11234
Education:
Medical School
First Leningrad I P Pavlov Medical Institute
Coney Island Hospital
Beth Israel Hosp-Harvard
First Leningrad I P Pavlov Medical Institute
Coney Island Hospital
Beth Israel Hosp-Harvard
Leonid Poretsky, New York NY
Leonid Poretsky, New York NY
Specialties:
Internal Medicine, Endocrinology and Metabolism, Endocrinology, Diabetes & Metabolism, Emergency Medicine
Work:
Beth Israel Medical Center
317 E 17Th St, New York, NY 10003
317 E 17Th St, New York, NY 10003
Education:
First Leningrad I P Pavlov Medical Institute (1977)
Use Of Thiazolidinediones For The Partial Inhibition Of Androgen Binding To Aromatase
Use Of Thiazolidinediones For The Partial Inhibition Of Androgen Binding To Aromatase
US Patent:
2012026, Oct 18, 2012
Filed:
Jun 27, 2012
Appl. No.:
13/535348
Inventors:
Donna Lin Tang Seto-Young - New York NY, US
Leonid Poretsky - New York NY, US
Leonid Poretsky - New York NY, US
International Classification:
A61K 31/4439, A61P 43/00, A61P 15/08
US Classification:
514342
Abstract:
A method for the treatment or prophylaxis of a disorder, wherein the disorder is affected by estrogen, comprising partially inhibiting aromatase activity or interfering with the binding of androgen to aromatase by administering a therapeutically effective amount of a thiazolidinedione to the patient. The use of rosiglitazone or pioglitazone to partially inhibit the binding of androgen to aromatase by at least 20% is preferred.
Use Of Thiazolidinediones For The Partial Inhibition Of Androgen Binding To Aromatase
Use Of Thiazolidinediones For The Partial Inhibition Of Androgen Binding To Aromatase
US Patent:
2009030, Dec 10, 2009
Filed:
May 11, 2009
Appl. No.:
12/463522
Inventors:
Donna Lin Tang Seto-Young - New York NY, US
Leonid Poretsky - New York NY, US
Leonid Poretsky - New York NY, US
International Classification:
A61K 31/4439
US Classification:
514342
Abstract:
A method for the treatment or prophylaxis of a disorder, wherein the disorder is affected by estrogen, comprising partially inhibiting aromatase activity or interfering with the binding of androgen to aromatase by administering a therapeutically effective amount of a thiazolidinedione to the patient. The use of rosiglitazone or pioglitazone to partially inhibit the binding of androgen to aromatase by at least 20% is preferred.
Newspaper Holder
Newspaper Holder
US Patent:
4861073, Aug 29, 1989
Filed:
Apr 26, 1988
Appl. No.:
7/186302
Inventors:
Leonid Poretsky - New York NY
International Classification:
B42D 500, B42D 900, A45C 1100, B32B 304
US Classification:
281 45
Abstract:
A paper-holding device includes transparent front and back panels that include a plurality of orthogonally oriented intersecting crease lines and a leaf which is mounted to overly the panels. The leaf magnifies material therebeneath, and is adapted, in one embodiment of the invention, to move on the holder. The holder is adapted to be folded in a manner that permits the paper to be folded to expose columns thereof for reading.